The role of osteoprotegerin (OPG) in exercise-induced skeletal muscle adaptation
Authors:
Open Access
- 9 December 2024
- journal article
- research article
- Published by Walter de Gruyter GmbH in Translational Exercise Biomedicine
- Vol. 2 (1) , 30-40
Abstract
Objectives: The purpose of this narrative review is to offer an updated perspective on the current research on the glycoprotein Osteoprotegerin (OPG), including its potential therapeutic impact and mechanisms of action, and interaction with bone and muscle tissues. Content: As health and social care advances people are living longer, with projections suggesting that in 2050 there will be 2 billion people who are aged over 60 years. Yet musculoskeletal health still declines into older age and as a result there is an increase in the proportion of older populations that spend more time with persistent disabilities. Although physical exercise is repeatedly demonstrated to minimise detrimental effects of ageing, it is not always a feasible intervention, and other directions must be considered. Summary and outlook: OPG, a glycoprotein decoy receptor for the receptor activator of nuclear factor kappa-β ligand (RANKL) is a key regulator of bone formation yet emerging evidence has presented its potential to offer positive outcomes in regard to the preservation of skeletal muscle mass and function. Animal models have shown that OPG levels increase during exercise, and independently acts to restore losses of muscle strength and reduce bone resorption. Interventions to increase circulating OPG alongside exercise may act as a therapeutic target to combat the decline in quality of life in older age in humans. Further research is needed on the mechanisms of its action and interaction in humans in combination with exercise.Keywords
This publication has 93 references indexed in Scilit:
- Role of Wnt signaling and sclerostin in bone and as therapeutic targets in skeletal disordersOsteoporosis International, 2022
- Beneficial effects of denosumab on muscle performance in patients with low BMD: a retrospective, propensity score-matched studyOsteoporosis International, 2022
- Characteristics of Long-Term Femoral Neck Bone Loss in Postmenopausal Women: A 25-Year Follow-UpJournal of Bone and Mineral Research, 2020
- Circulating levels of dickkopf-1, osteoprotegerin and sclerostin are higher in old compared with young men and women and positively associated with whole-body bone mineral density in older adultsOsteoporosis International, 2017
- Effects of plyometric exercise session on markers of bone turnover in boys and young menEuropean Journal of Applied Physiology, 2015
- Mechanical stretching induces osteoprotegerin in differentiating C2C12 precursor cells through noncanonical Wnt PathwaysJournal of Bone and Mineral Research, 2010
- RANKL, RANK, osteoprotegerin: key partners of osteoimmunology and vascular diseasesCellular and Molecular Life Sciences, 2007
- Osteoprotegerin (OPG)—a potential new role in the regulation of endothelialcell phenotype and tumour angiogenesis?International Journal of Cancer, 2005
- Injections of osteoprotegerin and PMA delay tooth eruptionClinical Anatomy, 2005
- Bone “mass” and the “mechanostat”: A proposalThe Anatomical Record, 1987